Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ELDN
#3003
Eledon Pharmaceuticals, Inc. Common Stock
2.6
2
+10.08%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+10.08%
Aylık değişim
+19.09%
6 aylık değişim
+1.55%
Yıllık değişim
-37.77%
Önceki kapanış
2.3
8
Open
2.6
2
Bid
Ask
Low
2.6
2
High
2.6
2
Hacim
55
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ELDN
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
59.74 M
59.88 M
59.88 M
59.88 M
59.93 M
—
Valuation ratios
Enterprise value
142 M
226.16 M
194.5 M
156.54 M
151.56 M
728.76 M
Price to earnings ratio
5.41
-5.49
-15.41
3.82
3.16
-13.93
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-2.16
-4.23
-3.12
-2.46
-2.55
-12.35
Price to book ratio
0.32
1.69
0.57
0.43
0.51
3.21
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.67
-0.62
0.04
0.08
0.13
-0.36
Return on equity %
1.01
-0.93
0.06
0.22
0.49
-0.15
Return on invested capital %
—
-95.28
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.53
12.42
13.91
8.12
6.74
41.18
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.21
0.39
0.21
0.23
0.19
1.02
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.41
2.89
1.62
1.39
1.21
7.11
Net current asset value per share
1.47
2.96
1.66
1.44
1.25
7.31
Tangible book value per share
1.37
2.43
1.49
0.65
0.46
5.03
Working capital per share
1.24
2.72
1.54
1.27
1.06
6.59
Book value per share
1.37
2.43
1.49
0.65
0.46
5.03
Haberler
Eledon Pharmaceuticals Guggenheim Zirvesi’nde: Tegoprubart’ın Umut Verici Yolu
Eledon Pharmaceuticals at Guggenheim Summit: Tegoprubart’s Promising Path
Eledon, tegoprubart için olumlu 24 aylık böbrek nakli verilerini açıkladı
Eledon reports positive 24-month kidney transplant data for tegoprubart
Eledon’un tegoprubart ilacı böbrek nakli denemelerinde umut veriyor
Eledon’s tegoprubart shows promise in kidney transplantation trials
Eledon Pharmaceuticals hisseleri olumlu adacık nakli verileri sonrası yükseldi
Eledon Pharmaceuticals stock rises after positive islet transplant data
Eledon’un anti-CD40L antikoru diyabet denemesinde umut veriyor
Eledon’s anti-CD40L antibody shows promise in diabetes trial
Guggenheim, seyreltme nedeniyle Eledon Pharmaceuticals hisse senedi fiyat hedefini düşürdü
Guggenheim lowers Eledon Pharmaceuticals stock price target on dilution